VEIN ABLATION DEVICE MARKET

INTRODUCTION

Varicose veins can be reduced by a treatment called endo venous laser varicose vein surgery. Swollen, protruding veins known as varicose veins frequently appear on the thighs or calves. A laser is a machine that emits a tiny beam of radiation that resembles light. 

The varicose vein is closed, shrunk, and the vessel develops scar tissue as a result of laser surgery. The vein is then sealed off.

The blood then travels via neighboring veins in its place. If your varicose veins are painful, red, and swollen, your healthcare practitioner might recommend laser surgery. If the skin around your varicose veins becomes inflamed, laser surgery may also be suggested.

Treatment for Varicose Veins In order to cauterize and seal varicose veins, endo venous ablation uses energy. It is used by doctors to treat symptoms like pain, edema, and irritation. Ablation is risk-free, less intrusive than surgery, and almost scar-scarless.

GLOBAL VEIN ABLATION DEVICE MARKET SIZE AND FORECAST

The Global Vein Ablation device market accountedfor $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

VEIN ABLATION DEVICE MARKET RECENT DEVELOPMENT

The first two VELEX cases were completed last week in Milan at the Policlinic San Donato center, a renowned medical research facility. VASC, an Italian start-up company, developed and received CE Marking for its novel percutaneous VELEXTM system to treat CVI, a condition that includes varicose vein disease.

The V.A.S.C. post-market clinical trial has officially begun with these first two cases. It will be carried out at a number of accredited facilities under the direction of Policlinic San Donato, most notably the San Raffaele Hospital in Milan and other international sites.

The revolutionary VELEX minimally invasive catheter technology, created and developed by Mario Salerno, delivers an enhanced kind of sclerotherapy based on the Empty Vein Ablation principle.

The sclerosant medication can be applied in a completely regulated manner to the vein segment that needs to be treated thanks to EVA technology. This section is drained of blood and isolated from the rest of the venous system prior to the drug injection; this quick and easy operation is intended to increase the safety and efficacy of sclerotherapy.

I-VASC CEO Daniele Zanetti said, "We are proud of having started the clinical use of VELEX in accordance with our product roll-out plans, and having done that at such a competent center as San Donato, with an experienced investigator Paolo Rohini (MD) and the remarkable team of Prof. Giovanni Nano.

VEIN ABLATION DEVICE MARKET COMPANY PROFILE

• Biotronik
• Lepu Medical
• Microport
• Syneron Medical Ltd
• Teleflex

THIS VEIN ABLATION DEVICE MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How manyVein Ablation deviceare manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a GlobalVein Ablation deviceand key vendor selection criteria
3. Where is the Vein Ablation device manufactured? What is the average margin per unit?
4. Market share of GlobalVein Ablation devicemarketmanufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture GlobalVein Ablation devicein-house
6. 5 key predictions for next 5 years in Global Vein Ablation devicemarket
7. Average B-2-B Vein Ablation devicemarket price in all segments
8. Latest trends inVein Ablation devicemarket, by every market segment
9. The market size (both volume and value) of theVein Ablation devicemarket in 2024-2030 and every year in between?
10.  Production breakup of Vein Ablation devicemarket, by suppliers and their OEM relationship